Xilio Therapeutics (XLO) EPS (Basic) (QoQ) (2020 - 2026)
Xilio Therapeutics (XLO) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Xilio Therapeutics | 178.33 Mn | 42.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.38% |
| Mar 31, 2026 | 39.09% |
| Dec 31, 2025 | -631.50% |
| Sep 30, 2025 | 90.72% |
| Jun 30, 2025 | 19.79% |
| Mar 31, 2025 | 28.37% |
| Dec 31, 2024 | -11.02% |
| Sep 30, 2024 | 9.10% |
| Jun 30, 2024 | 59.61% |
| Mar 31, 2024 | 4.47% |
| Dec 31, 2023 | -5.58% |
| Sep 30, 2023 | 13.98% |
| Jun 30, 2023 | 15.03% |
| Mar 31, 2023 | 2.95% |
| Dec 31, 2022 | -19.60% |
| Sep 30, 2022 | 17.77% |
| Jun 30, 2022 | -15.80% |
| Mar 31, 2022 | 77.67% |
| Dec 31, 2021 | 91.57% |
| Sep 30, 2021 | -32.47% |